INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 426m ago
HOUSE PTR25m ago
SEC 13F25m ago
ROBINHOOD CHAIN25m ago
AM
Corporate insider

Anderson Elizabeth M

DirectorCIK 0001758247

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 6
Max Insider Score39
Connections with evidence2

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
AM
Anderson Elizabeth MDirector
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M—
5,070 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Revolution Medicines, Inc.Director · Sep 24, 2026
  • Insider ofevidence
    INSMED IncDirector · Nov 26, 2025
34
AM
Anderson Elizabeth MDirector
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL
$960K
4,985 sh
Sep 22, 2026
Sep 24, 2026
traded Sep 22, 2026
+2d
SEC FORM 4

Evidence

27
AM
Anderson Elizabeth MDirector
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
910 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

11
AM
Anderson Elizabeth MDirector
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M$5,678
5,070 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

34
AM
Anderson Elizabeth MDirector
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$512K
2,648 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

34
AM
Anderson Elizabeth MDirector
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$292K
1,500 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

20
AM
Anderson Elizabeth MDirector
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
100 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

39
AM
Anderson Elizabeth MDirector
INSMINSMED Inc
Open-market sale
SELL$1.02M
5,000 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence